ArticleThe oncologist2022

Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma.

Andrzej J Jakubowiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.